ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,722,151 | -48.6% | 959,906 | -1.5% | 0.00% | -50.0% |
Q2 2023 | $20,860,228 | -40.2% | 974,777 | +12.9% | 0.00% | -42.9% |
Q1 2023 | $34,912,499 | -15.0% | 863,316 | -2.2% | 0.01% | -22.2% |
Q4 2022 | $41,083,208 | -17.9% | 883,130 | -8.4% | 0.01% | -18.2% |
Q3 2022 | $50,023,000 | +13.6% | 964,407 | +3.6% | 0.01% | +22.2% |
Q2 2022 | $44,022,000 | -33.4% | 931,291 | +0.3% | 0.01% | -25.0% |
Q1 2022 | $66,061,000 | -12.7% | 928,093 | -8.3% | 0.01% | 0.0% |
Q4 2021 | $75,689,000 | +38.9% | 1,012,164 | +5.5% | 0.01% | +20.0% |
Q3 2021 | $54,483,000 | +90.8% | 959,048 | +47.8% | 0.01% | +100.0% |
Q2 2021 | $28,554,000 | -10.2% | 648,802 | +0.6% | 0.01% | -16.7% |
Q1 2021 | $31,807,000 | +217.8% | 644,914 | +171.3% | 0.01% | +200.0% |
Q4 2020 | $10,009,000 | -11.9% | 237,729 | -4.2% | 0.00% | 0.0% |
Q3 2020 | $11,355,000 | -11.2% | 248,041 | -2.6% | 0.00% | -33.3% |
Q2 2020 | $12,787,000 | -3.8% | 254,660 | -1.5% | 0.00% | -25.0% |
Q1 2020 | $13,298,000 | -8.1% | 258,566 | +10.4% | 0.00% | +33.3% |
Q4 2019 | $14,476,000 | -0.3% | 234,298 | -3.0% | 0.00% | 0.0% |
Q3 2019 | $14,518,000 | -26.5% | 241,647 | +3.3% | 0.00% | -40.0% |
Q2 2019 | $19,749,000 | -10.6% | 234,037 | +1.1% | 0.01% | 0.0% |
Q1 2019 | $22,101,000 | +29.6% | 231,380 | -3.9% | 0.01% | 0.0% |
Q4 2018 | $17,055,000 | -13.8% | 240,803 | +4.0% | 0.01% | 0.0% |
Q3 2018 | $19,792,000 | -23.7% | 231,596 | +3.4% | 0.01% | -28.6% |
Q2 2018 | $25,955,000 | +67.2% | 223,943 | +16.7% | 0.01% | +75.0% |
Q1 2018 | $15,521,000 | +32.0% | 191,830 | -4.3% | 0.00% | +33.3% |
Q4 2017 | $11,757,000 | +28.5% | 200,357 | +2.5% | 0.00% | +50.0% |
Q3 2017 | $9,151,000 | +30.0% | 195,523 | -0.1% | 0.00% | 0.0% |
Q2 2017 | $7,041,000 | +21.6% | 195,712 | +4.1% | 0.00% | 0.0% |
Q1 2017 | $5,789,000 | -9.2% | 187,940 | -1.2% | 0.00% | 0.0% |
Q4 2016 | $6,375,000 | +31.1% | 190,311 | +4.1% | 0.00% | 0.0% |
Q3 2016 | $4,864,000 | +24.6% | 182,817 | +3.3% | 0.00% | +100.0% |
Q2 2016 | $3,904,000 | -28.7% | 177,047 | -5.0% | 0.00% | -50.0% |
Q1 2016 | $5,475,000 | -8.5% | 186,373 | +2.8% | 0.00% | 0.0% |
Q4 2015 | $5,985,000 | -6.5% | 181,269 | +2.3% | 0.00% | 0.0% |
Q3 2015 | $6,402,000 | +9.4% | 177,159 | +36.2% | 0.00% | 0.0% |
Q2 2015 | $5,850,000 | +58.3% | 130,039 | +7.8% | 0.00% | +100.0% |
Q1 2015 | $3,696,000 | -39.7% | 120,676 | +0.1% | 0.00% | -50.0% |
Q4 2014 | $6,129,000 | +27.7% | 120,533 | -0.7% | 0.00% | 0.0% |
Q3 2014 | $4,800,000 | +97.4% | 121,322 | +114.9% | 0.00% | +100.0% |
Q2 2014 | $2,431,000 | +18.6% | 56,443 | +10.2% | 0.00% | 0.0% |
Q1 2014 | $2,049,000 | +40.3% | 51,239 | -4.2% | 0.00% | – |
Q4 2013 | $1,460,000 | +28.6% | 53,513 | +8.0% | 0.00% | – |
Q3 2013 | $1,135,000 | +378.9% | 49,536 | +269.7% | 0.00% | – |
Q2 2013 | $237,000 | – | 13,398 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |